Characteristics of Tripeptide Transport in Human Jejunal Brush-border Membrane Vesicles
Overview
Biophysics
Authors
Affiliations
These studies are aimed at characterizing the transport of the tripeptide, glycylglycyl-L-proline (GlyGlyPro) across human jejunal brush-border membrane vesicles. GlyGlyPro (0.65 mM) was hydrolyzed by brush-border membrane vesicles with the extent of hydrolysis per mg protein being 23% at 0.5 min, 57% at 1 min and complete hydrolysis at 60 min. Treatment of the membrane vesicles with gel-complexed papain (to remove membrane peptidases) resulted in minimal hydrolysis of GlyGlyPro up to 10 min of incubation. Measurement of GlyGlyPro influx with papain-treated vesicles in the presence of increasing medium osmolarity showed that uptake occurred into an osmotically reactive intravesicular space. Transport of GlyGlyPro with normal and papain-treated membrane vesicles was similar in the presence of an inward Na+ or K+ gradient. No overshoot phenomenon was observed in the presence of an inward proton gradient (extravesicular pH 5.5; intravesicular pH 7.5). An interior negative membrane potential induced by a K+ diffusion potential in the presence of valinomycin stimulated the uptake of the peptide. The effect of increasing concentrations on initial rates of GlyGlyPro uptake revealed the presence of a saturable component as well as a diffusional component. Preloading the membrane vesicles with 20 mM glycylsarcosylsarcosine stimulated uptake by 4-fold. Uptake of GlyGlyPro was inhibited greater than 50% by dipeptides and tripeptides and less than 15% by free amino acids. These results indicate that GlyGlyPro uptake in jejunal brush-border membrane vesicles is not energized by a Na+ or proton gradient and that transport occurs by carrier-mediated and diffusional processes.
Chalova V, Sirsat S, OBryan C, Crandall P, Ricke S Sensors (Basel). 2012; 9(9):7038-57.
PMID: 22399985 PMC: 3290505. DOI: 10.3390/s90907038.
Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles.
Poschet J, Hammond S, Fairclough P Gut. 1999; 44(5):620-4.
PMID: 10205196 PMC: 1727494. DOI: 10.1136/gut.44.5.620.
SNYDER N, Tabas L, Berry D, Duckworth D, Spry D, Dantzig A Antimicrob Agents Chemother. 1997; 41(8):1649-57.
PMID: 9257735 PMC: 163979. DOI: 10.1128/AAC.41.8.1649.
Thwaites D, Simmons N, Hirst B Pharm Res. 1993; 10(5):667-73.
PMID: 8391693 DOI: 10.1023/a:1018995313180.
Enteral absorption of octreotide.
Fricker G, Drewe J, Vonderscher J, Kissel T, Beglinger C Br J Pharmacol. 1992; 105(4):783-6.
PMID: 1504712 PMC: 1908725. DOI: 10.1111/j.1476-5381.1992.tb09057.x.